本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Cytokinetics

44.97
-1.6050-3.45%
成交量:34.80萬
成交額:1,566.15萬
市值:53.24億
市盈率:-8.54
高:46.07
開:46.07
低:44.26
收:46.57
資料載入中...

公司資料

公司名字:
Cytokinetics
交易所:
NASDAQ
成立時間:
1997
員工人數:
498
公司地址:
350 Oyster Point Boulevard,South San Francisco,California,United States
郵編:
94080
電話:
傳真:
- -
簡介:
Cytokinetics, Incorporated於1997年8月5日成立,符合特拉華州的法律規定。它是一家處於臨床階段的生物製藥公司,主要致力於為重大疾病和糟糕的醫療條件提供潛在的治療方法的這樣一種調節肌肉功能的新型小分子治療方法的發現和發展。它目前處於發展階段,着重於科研,開發藥品篩選技術和融資。

董事

名稱
職位
L. Patrick Gage
Independent Director, Chairman
Robert I. Blum
Director, President and Chief Executive Officer
B. Lynne Parshall
Independent Director
Edward M. Kaye
Independent Director
John T. Henderson
Independent Director
Robert M. Califf
Independent Director
Sandford D. Smith
Independent Director
Santo J. Costa
Independent Director
Wendell Wierenga
Independent Director

股東

名稱
職位
Robert I. Blum
Director, President and Chief Executive Officer
Ching Jaw
Senior Vice President, Chief Financial Officer
Mark A. Schlossberg, Esq.
Senior Vice President, Legal, General Counsel and Secretary
David W. Cragg
Chief Human Resources and Administration Officer
Fady I. Malik
Executive Vice President, Research and Development